Effect of Diet Orange Soda on Urinary Lithogenicity
1 other identifier
interventional
12
1 country
1
Brief Summary
Beverages containing citrate may be useful in increasing urine citrate content and urine pH. Such changes in urine chemistry could help prevent kidney stones. Diet orange soda has more citrate than other similar beverages. The investigators are interested in whether diet soda will improve urine chemistry in the appropriate manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
April 4, 2011
CompletedFirst Posted
Study publicly available on registry
April 7, 2011
CompletedSeptember 10, 2012
September 1, 2012
8 months
April 4, 2011
September 6, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in urine citrate content
Citrate is measured in 24h urine sample and expressed as mg/day
1 week
Secondary Outcomes (1)
Change in urine pH
One week
Study Arms (2)
Water drinking
PLACEBO COMPARATOR32 ounces of water/24 hours
orange soda drinking
ACTIVE COMPARATOR32 ounces orange soda
Interventions
Eligibility Criteria
You may qualify if:
- years old
- able to sign consent
- ability to reliably urinate into a vessel and measure urine volume
You may not qualify if:
- prior history of nephrolithiasis
- a known history of metabolic bone disease
- hyperthyroidism
- hyperparathyroidism or chronic kidney disease
- current use of diuretics
- current use of potassium citrate or other oral alkali supplementation and
- use of calcium supplementation that could not be stopped
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York Harbor VA Medical Center
New York, New York, 10010, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David S Goldfarb, MD
New York Harbor VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief, Nephrology
Study Record Dates
First Submitted
April 4, 2011
First Posted
April 7, 2011
Study Start
November 1, 2009
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
September 10, 2012
Record last verified: 2012-09